|
ABHD14A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.009600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.695900E-02 |
| Normal-vs-Stage2 |
2.302700E-03 |
| Normal-vs-Stage3 |
9.966000E-01 |
| Normal-vs-Stage4 |
9.980400E-01 |
| Stage1-vs-Stage2 |
1.427570E-02 |
| Stage1-vs-Stage3 |
1.632640E-01 |
| Stage1-vs-Stage4 |
3.039000E-01 |
| Stage2-vs-Stage3 |
3.537400E-03 |
| Stage2-vs-Stage4 |
1.053960E-02 |
| Stage3-vs-Stage4 |
9.957800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.724400E-01 |
| Normal-vs-AfricanAmerican |
6.936400E-01 |
| Normal-vs-Asian |
3.005200E-01 |
| Caucasian-vs-AfricanAmerican |
9.138600E-01 |
| Caucasian-vs-Asian |
7.293600E-01 |
| AfricanAmerican-vs-Asian |
7.309600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.034500E-02 |
| Normal-vs-Female |
2.986400E-01 |
| Male-vs-Female |
4.274400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.249400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.644220E-01 |
| Normal-vs-Age(61-80Yrs) |
6.978000E-02 |
| Normal-vs-Age(81-100Yrs) |
8.649800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.248200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.367400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.515000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.180200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.294800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.478600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.70729999424435E-09 |
| Classical-VS-Follicular |
7.55149999975835E-07 |
| Classical-VS-Other |
1.767180E-01 |
| Classical-VS-Normal |
6.223000E-01 |
| Tall-VS-Follicular |
1.64035451888367E-12 |
| Tall-VS-Other |
5.178100E-02 |
| Tall-VS-Normal |
2.58000000030734E-07 |
| Follicular-VS-Other |
5.382400E-01 |
| Follicular-VS-Normal |
5.11690000037923E-07 |
| Other-VS-Normal |
3.196400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.228000E-04 |
| Normal-vs-N1 |
6.381000E-01 |
| N0-vs-N1 |
8.586000E-02 |
|
|
